Company: GOOGL
Filing Date: 2025-05-01
Form Type: 424B2
Source: 0001193125-25-110061
Chunk: 17

Company: Alphabet Inc.
Filing Date: 2025-05-01
Form: 424B2
Chunk 17
---
 be used for general corporate purposes, which may include the repayment 
 of outstanding debt. Settlement of this offering is not conditioned upon the settlement of the Concurrent USD Notes Offering or vice versa.                                                                                                 |

| The Concurrent USD Notes Offering is only being made pursuant to a separate prospectus supplement. This prospectus supplement                       
 is not an offer to sell or a solicitation of an offer to buy any securities being offered in the Concurrent USD Notes Offering or vice versa. There |

S-6

| can be no assurance that we will complete the Concurrent USD Notes Offering as described herein or at all. |

| Risk Factors | You should consider carefully all the information set forth and incorporated by reference in this prospectus supplement and the accompanying prospectus and, in particular, you should evaluate the specific factors set forth under the heading 
 “Risk Factors” beginning on page S-8 of this prospectus supplement, as well as the other information contained or incorporated herein by reference, before investing in any of the notes offered hereby.                                         |

| Governing Law | New York. |

| Trustee, Registrar and Transfer Agent | The Bank of New York Mellon Trust Company, N.A. |

| Paying Agent | The Bank of New York Mellon, London Branch. |

| ISIN | 2029 Notes: XS3064418687 |

| 2033 Notes: XS3064423174 |

| 2037 Notes: XS3064425468 |

| 2045 Notes: XS3064427837 |

| 2054 Notes: XS3064430385 |

| Common Code | 2029 Notes: 306441868 |

| 2033 Notes: 306442317 |

| 2037 Notes: 306442546 |

| 2045 Notes: 306442783 |

| 2054 Notes: 306443038 |

S-7

RISK FACTORS

An investment in the notes involves certain risks. You should carefully consider the risk factors described under “Risk Factors” in our 2024 Annual
Report and as described in the Q1 2025 Quarterly Report, as well as the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus, before making an investment decision. Additional risks and
uncertainties not now known to us or that we now deem immaterial may also adversely affect our business or financial performance. Our business, financial condition, results of operations or cash flows could be materially adversely affected by any of
these risks. The market or trading price of